P4.11D.09 Fianlimab-Based Combination Therapies in Patients with Advanced Non-Small Cell Lung Cancer: Trials in Progress Updates von Melkadze, T., Gogishvili, M., Makharadze, T., Arkania, E., Kuchava, V., Lee, K.H., Zhvania, M., Brungs, D., Chikhladze, N., Hrom, J.S., Ahn, H.K., Porter, J., Goldberg, S., Reck, M., Peters, S., Baramidze, A.

Volltext

OA08.04 Plinabulin/Docetaxel vs. Docetaxel in 2L/3L NSCLC after Platinum Regimens (DUBLIN-3): A Phase 3 Randomized Controlled Trial von Feinstein, T., Han, B., Shi, Y., Chen, G., Yao, Y., Hu, C., Shi, J., Feng, J., Wu, H., Chen, Y., Guo, Q-s., Jie, Z., Ye, F., Zhang, Y., Liu, Z., Mao, W., Zhang, L., Lu, J., Zhao, J., Bazhenova, L., Ruiz, J., Kloecker, G., Kalmadi, S., Oliff, I., Wong, M., Liu, B., Wu, Y., Huang, L., Sun, Y., Luo, F., Zhou, J-y., Pan, H., Wang, H., Liu, C., Cao, L., Huang, C., Thara, E., Li, X., Jiang, D., Mowat, R.B., Hrom, J.S., Nagrial, A., Jain, V., Karim, N.A., Shunyakov, L.V., Kiberu, A., Jennens, R., Lloyd, K., Wang, Z., Du, L.

Volltext